A study scheduled for Nature Communications in 2026 reported that exposure to human chorionic gonadotropin (hCG) on the trigger day can affect downstream DNA methylation patterns and neurodevelopment-related outcomes signals. The work, led by Jiang, Wei, Liu and colleagues, describes mechanistic links between ART timing cues and lasting molecular changes. The report centers on how biochemical signals during IVF-related cycles may leave detectable epigenetic marks in offspring. While ART already allows clinicians to manage many cycle variables, identifying specific molecular impacts tied to trigger-day exposure may inform future monitoring and optimization. As the evidence matures, the key translational question will be whether the observed methylation changes correlate with measurable neurodevelopment endpoints and whether clinical protocol adjustments can reduce any risk signals.